2021
DOI: 10.1186/s12887-020-02490-2
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and safety of the syrup “KalobaTUSS®” as a treatment for cough in children: a randomized, double blind, placebo-controlled clinical trial

Abstract: Background Acute cough in children often causes discomfort to children and parents, reducing their quality of life. Despite the extensive utilization of over-the-counter remedies for cough, the efficacy of most of these treatments in children has not been confirmed. Methods We conducted a randomized, double blind, placebo-controlled clinical trial of 106 children with acute cough to evaluate the efficacy and safety of KalobaTUSS®, a paediatric coug… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 26 publications
0
8
0
Order By: Relevance
“…Paulsen [30], in agreement with Amorim [31], later cautioned towards the systemic allergic dermatitis associated with SL-containing plants in general, while emphasising the need to determine the pathogenesis of haptens, associated with the plant species, more specifically. Clinical data for the herb is limited, with one randomised, double-blind, placebo-controlled clinical trial documented for a cough syrup (KalaboTUSS ® ), which proved to be safe and efficacious [32]. Regarding isolated compounds, there are conflicting reports of sensitization [33][34][35] and opposing anti-allergenic properties [36,37].…”
Section: Traditional Use To Modern Researchmentioning
confidence: 99%
“…Paulsen [30], in agreement with Amorim [31], later cautioned towards the systemic allergic dermatitis associated with SL-containing plants in general, while emphasising the need to determine the pathogenesis of haptens, associated with the plant species, more specifically. Clinical data for the herb is limited, with one randomised, double-blind, placebo-controlled clinical trial documented for a cough syrup (KalaboTUSS ® ), which proved to be safe and efficacious [32]. Regarding isolated compounds, there are conflicting reports of sensitization [33][34][35] and opposing anti-allergenic properties [36,37].…”
Section: Traditional Use To Modern Researchmentioning
confidence: 99%
“…MDMSs are often used to treat coughs in children, and some data are present in the literature (Canciani et al, 2014;Cohen et al, 2017;Carnevali et al, 2021). Acute cough associated with upper respiratory tract infections is a frequent cause of distress and sleep disturbance, and the reason for many paediatric visits and drug prescriptions.…”
Section: Medical Device Made Of Substances In Paediatricsmentioning
confidence: 99%
“…Acute cough associated with upper respiratory tract infections is a frequent cause of distress and sleep disturbance, and the reason for many paediatric visits and drug prescriptions. MDMSs seem to be effective and safe in reducing acute and persistent cough in children, leading to a reduction in the use of specific drugs in this age group (Canciani et al, 2014;Cohen et al, 2017;Carnevali et al, 2021).…”
Section: Medical Device Made Of Substances In Paediatricsmentioning
confidence: 99%
“…The safety and efficacy of a pediatric cough syrup KalobaTUSS ® , which consists of acacia honey and extracts from Inula helenium L., M. sylvestris , Helichrysum stoechas (L.) Moench and Plantago major L. have been evaluated in a randomized controlled trial [ 20 ]. One hundred and six children with persistent cough were recruited for the study and were treated with cough syrup or a placebo at four times, 5 mL doses daily for eight days.…”
Section: Food Supplements and Childhood Illnessesmentioning
confidence: 99%